• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Zealand Pharma to Attend Jefferies London Healthcare Conf.

    GLOBENEWSWIRE

    Zeal& Pharma Share Transactions by Management & Associated Persons

    GLOBENEWSWIRE

    Zealand Pharma Starts Phase 2b Trial for Obesity Drug in Q4

    REUTERS

    Zealand Pharma Announces Financial Results for 9 Months of 2024

    GLOBENEWSWIRE

    Zealand Pharma to Present Q3 2024 Financial Results on Nov 7

    GLOBENEWSWIRE

    Zealand Pharma Provides Update On Dasiglucagon In CHI

    GLOBENEWSWIRE

    FDA declines to approve Zealand drug for low blood sugar in infants

    REUTERS

    Zealand And Boehringer Win FDA Breakthrough For Fatty Liver

    REUTERS

    Zealand Pharma Reports Total Shares & Voting Rights As Of Sept 30

    GLOBENEWSWIRE

    Zealand Pharma To Attend 2024 Cantor Global Healthcare Conference

    GLOBENEWSWIRE

    Zealand Pharma Increases Share Capital From Employee Warrants

    GLOBENEWSWIRE

    Weight-loss market to see 16 new drugs by 2029, report estimates

    EXPRESSPHARMA

    Zealand Pharma`s GLP-1/GLP-2 Agonist Achieves 8.3% Weight Loss

    FIERCE BIOTECH

    Zealand Pharma Announces Positive Topline Results

    GLOBENEWSWIRE

    Total number of shares and voting rights in Zealand Pharma on August 30, 2024

    GLOBENEWSWIRE

    Zealand Pharma Reports Transactions In Shares By Management

    GLOBENEWSWIRE

    Zealand Pharma Increases Share Capital From Employee Warrants

    GLOBENEWSWIRE

    Zealand Pharma major shareholder announcement: Bank of America Corporation

    GLOBENEWSWIRE

    Zealand Pharma Announces Financial Results for the First Half of 2024

    GLOBENEWSWIRE

    Zealand Pharma seeks big pharma partners for obesity drug candidate

    REUTERS

    Zealand Pharma To Present H1 2024 Results On August 15

    GLOBENEWSWIRE

    Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

    GLOBENEWSWIRE

    Pharma’s Obsession With Obesity On Rise

    BIOSPECTRUM ASIA

    Total number of shares and voting rights in Zealand Pharma at June 28, 2024

    GLOBENEWSWIRE

    Zealand Pharma major shareholder announcement: Van Herk Investments

    GLOBENEWSWIRE

    Zealand Pharma completes registration of capital increase

    GLOBENEWSWIRE

    ICPO Theranostics Virtual Summit on Cancer Care, Nov 14-15, 2024

    GLOBENEWSWIRE

    Zealand Launches Equity Offering Raising USD 900 Million / DKK 6.257 Billion

    GLOBENEWSWIRE

    Zealand announces completion of an upsized equity offering of 8.35 million

    GLOBENEWSWIRE

    Zealand Pharma Reports Positive Phase 1b Results For Petrelintide Trial

    GLOBENEWSWIRE

    Zealand Increases its Share Capital of Exercise of Employee Warrants

    GLOBENEWSWIRE

    Zealand: Boehringer`s Survodutide Cut Fibrosis, No MASH Worsening

    GLOBENEWSWIRE

    Zealand: Boehringer To Present Positive Survodutide MASH Trial At EASL

    GLOBENEWSWIRE

    Zealand`s Dasiglucagon Severe Hypoglycemia Med Gets CHMP Nod

    GLOBENEWSWIRE

    Zealand Pharma At June 2024 Healthcare Investor Conferences

    GLOBENEWSWIRE

    Zealand Pharma major shareholder announcement: Polar Capital

    GLOBENEWSWIRE

    Zealand`s dapiglutide shows little weight loss at lowest doses

    FIERCE BIOTECH

    Zealand Dapiglutide Topline Results: Glp-1/2 Dual Agonist Dream Trial

    GLOBENEWSWIRE

    Zealand Pharma Announces Financial Results for the First Quarter of 2024

    GLOBENEWSWIRE

    Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand

    ENDPTS

    Zealand Pharma Insider Share Transactions Disclosure

    GLOBENEWSWIRE

    Zealand Pharma Q1 2024 Results Call On May 16

    GLOBENEWSWIRE

    Zealand Partners with Benchling to Advance R&D of Engineered Peptide Medicines

    PR NEWSWIRE

    Zealand Launches 2024 LTI Programs For Board, Management, Employees

    GLOBENEWSWIRE

    Zealand Pharma Director/Management Transactions Reported

    GLOBENEWSWIRE

    Correction to Company announcement - No. 23 / 2024

    GLOBENEWSWIRE

    Total number of shares and voting rights in Zealand Pharma at March 31, 2024

    GLOBENEWSWIRE

    Zealand Pharma Increases its Share Capital as a Consequence of Exercise of EW

    GLOBENEWSWIRE

    Transactions in Zealand Pharma shares and/or related securities

    GLOBENEWSWIRE

    Zealand Pharma major shareholder announcement: Van Herk Investments

    GLOBENEWSWIRE

    Zealand Pharma`s Annual General Meeting 2024

    GLOBENEWSWIRE

    Transactions in Zealand shares &/or related securities by persons discharging

    GLOBENEWSWIRE

    Zealand Pharma major shareholder announcement: Polar Capital

    GLOBENEWSWIRE

    New Employee Elected Directors to the Board of Zealand Pharma A/S

    GLOBENEWSWIRE

    Transactions in Zealand Pharma shares and/or related securities

    GLOBENEWSWIRE

    Zealand Pharma Increases its Share Capital

    GLOBENEWSWIRE

    Transactions in Zealand Pharma shares and/or related securities

    GLOBENEWSWIRE

    Zealand Pharma to Participate in TD Cowen™s 44th Annual Health Care Conference

    GLOBENEWSWIRE

    Zealand Pharma Announces Financial Results for the Full Year 2023

    GLOBENEWSWIRE

    Obesity drug from Boehringer, Zealand succeeds in MASH trial

    BIOPHARMA DIVE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.